ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

Ominous Note: Magnuson Hints Senate May Cut NCI Budget 5% Under President’s 1980 Request

March 9, 1979

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012